Ikuta Tanaka

825 total citations
9 papers, 569 citations indexed

About

Ikuta Tanaka is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Ikuta Tanaka has authored 9 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Genetics and 3 papers in Immunology. Recurrent topics in Ikuta Tanaka's work include Platelet Disorders and Treatments (2 papers), Periodontal Regeneration and Treatments (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Ikuta Tanaka is often cited by papers focused on Platelet Disorders and Treatments (2 papers), Periodontal Regeneration and Treatments (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Ikuta Tanaka collaborates with scholars based in Japan. Ikuta Tanaka's co-authors include Yoshiro Niitsu, Takuya Matsunaga, Yutaka Kawano, Masayoshi Kobune, Tsutomu Sato, Junji Kato, Rishu Takimoto, Hiroyuki Kuroda, Yasuo Hirayama and Takehide Akiyama and has published in prestigious journals such as Nature Medicine, Blood and Stem Cells.

In The Last Decade

Ikuta Tanaka

8 papers receiving 562 citations

Peers

Countries citing papers authored by Ikuta Tanaka

Since Specialization

Citations

This map shows the geographic impact of Ikuta Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuta Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuta Tanaka more than expected).

Fields of papers citing papers by Ikuta Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuta Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuta Tanaka. The network helps show where Ikuta Tanaka may publish in the future.

Co-authorship network of co-authors of Ikuta Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Ikuta Tanaka. A scholar is included among the top collaborators of Ikuta Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikuta Tanaka. Ikuta Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	[Clinical study of sigmoid volvulus at eleven core hospitals in the Kagawa Prefecture]. 2021 ·PubMed ·Masaki Wato, (unknown), Tomoki Inaba, Fumihiko Kinekawa, (unknown), Mitsuyoshi Kobayashi, (unknown), (unknown), Hideyuki Inoue, Ikuta Tanaka, Keiichi Okano, (unknown)	0
2	Ex Vivo Large‐Scale Generation of Human Platelets from Cord Blood CD34 ⁺ Cells 2006 ·Stem Cells ·Takuya Matsunaga, Ikuta Tanaka, Masayoshi Kobune, Yutaka Kawano, Maki Tanaka, Kageaki Kuribayashi, Satoshi Iyama, Tsutomu Sato, Yasushi Sato, Rishu Takimoto, Tetsuji Takayama, Junji Kato, Takafumi Ninomiya, Hirofumi Hamada, Yoshiro Niitsu	95
3	[Psoriasis vulgaris exacerbated by imatinib therapy in chronic myelogenous leukemia]. 2005 ·PubMed ·Ken‐ichi Shimizu, Hiroyuki Kuroda, M Kida, Hideki Watanabe, (unknown), Takehide Akiyama, Akihito Fujimi, Ikuta Tanaka, Tsutomu Sato, Takuya Matsunaga, Yoshiro Niitsu	7
4	Ex Vivo Large Scale Generation of Human Platelets from Cord Blood CD34+ Cells. 2005 ·Blood ·Takuya Matsunaga, Ikuta Tanaka, Masayoshi Kobune, Yutaka Kawano, Maki Tanaka, Takehide Akiyama, Kageaki Kuribayashi, Takafumi Ninomiya, Hirofumi Hamada, Yoshiro Niitsu	5
5	Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia 2003 ·Nature Medicine ·Takuya Matsunaga, Naofumi Takemoto, Tsutomu Sato, Rishu Takimoto, Ikuta Tanaka, Akihito Fujimi, Takehide Akiyama, Hiroyuki Kuroda, Yutaka Kawano, Masayoshi Kobune, Junji Kato, Yasuo Hirayama, Sumio Sakamaki, Kyuhei Kohda, Kensuke Miyake, Yoshiro Niitsu	445
6	Decrease of Smad4 gene expression in patients with essential thrombocythaemia may cause an escape from suppression of megakaryopoiesis by transforming growth factor‐β1 2003 ·British Journal of Haematology ·Hiroyuki Kuroda, Takuya Matsunaga, Takeshi Terui, Ikuta Tanaka, Rishu Takimoto, Koshi Fujikawa, Tetsuji Takayama, Junji Kato, Yasuo Hirayama, Sumio Sakamaki, Kyuhei Kohda, Yoshiro Niitsu	14
7	A patient with paroxysmal nocturnal haemoglobinuria in whom granulocyte colony‐stimulating factor administration resulted in improvement of recurrent enterocolitis and its associated haemolytic attacks 2002 ·British Journal of Haematology ·Akihito Fujimi, Takuya Matsunaga, Katsuhisa Kogawa, (unknown), (unknown), Tomoyuki Abe, (unknown), Takahiro Kogawa, Ikuta Tanaka, (unknown), Takeshi Terui, Sumio Sakamaki, Junji Kato, (unknown), Takeshi Maeda, Yoshiro Niitsu	1
8	[Successful treatment with G-CSF and corticosteroid of adult idiopathic autoimmune neutropenia presenting as recurrent enterocolitis]. 2002 ·PubMed ·Akihito Fujimi, Takuya Matsunaga, (unknown), Naofumi Takemoto, Ikuta Tanaka, Takehide Akiyama, Tsutomu Sato, (unknown), Takeshi Terui, Katsuhisa Kogawa, Junji Kato, Michiaki Hirayama, (unknown), Sumio Sakamaki, Yoshiro Niitsu	1
9	[Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis]. 2002 ·PubMed ·Daisuke Takahari, Takuya Matsunaga, Akihito Fujimi, Tomoki Kikuchi, (unknown), Ikuta Tanaka, Naofumi Takemoto, Takehide Akiyama, Tsutomu Sato, Takeshi Terui, Katsuhisa Kogawa, Junji Kato, (unknown), Takeshi Maeda, Yoshiro Niitsu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact